149 related articles for article (PubMed ID: 19644649)
21. Osteogenic sarcoma.
Berg EE
Orthop Nurs; 2006; 25(5):348-9; quiz 350-1. PubMed ID: 17035924
[No Abstract] [Full Text] [Related]
22. Hearing loss during osteosarcoma chemotherapy: when acute ifosfamide toxicity revealed unnoticed methotrexate encephalopathy.
Robert G; Chappé C; Taque S; Bruneau B; Gandemer V
J Pediatr Hematol Oncol; 2014 Mar; 36(2):e100-2. PubMed ID: 24309600
[TBL] [Abstract][Full Text] [Related]
23. EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma.
Ferrari S; Bielack SS; Smeland S; Longhi A; Egerer G; Sundby Hall K; Donati D; Kevric M; Brosjö O; Comandone A; Werner M; Monge O; Palmerini E; Berdel WE; Bjerkehagen B; Paioli A; Lorenzen S; Eriksson M; Gambarotti M; Tunn PU; Jebsen NL; Cesari M; von Kalle T; Ferraresi V; Schwarz R; Bertulli R; Kasparek AK; Grignani G; Krasniqi F; Sorg B; Hecker-Nolting S; Picci P; Reichardt P
Tumori; 2018; 104(1):30-36. PubMed ID: 29218692
[TBL] [Abstract][Full Text] [Related]
24. Osteosarcoma and other tumors of bone.
Mertens WC; Bramwell V
Curr Opin Oncol; 1995 Jul; 7(4):349-54. PubMed ID: 7578383
[TBL] [Abstract][Full Text] [Related]
25. Multidisciplinary approach to osteosarcoma.
Biazzo A; De Paolis M
Acta Orthop Belg; 2016 Dec; 82(4):690-698. PubMed ID: 29182106
[TBL] [Abstract][Full Text] [Related]
26. Calcaneal insufficiency fracture in a child with osteosarcoma after chemotherapy and limb-sparing surgery.
Osanai T; Tsuchiya T; Sugawara M
Arch Orthop Trauma Surg; 2007 Aug; 127(6):465-8. PubMed ID: 17103179
[TBL] [Abstract][Full Text] [Related]
27. Primary osteoliposarcoma of the bone.
De Padua M; Bhandari TP; Pingle J
Indian J Pathol Microbiol; 2009; 52(1):80-2. PubMed ID: 19136790
[TBL] [Abstract][Full Text] [Related]
28. Significance of neoadjuvant chemotherapy (NACT) in limb salvage treatment of osteosarcoma and its effect on GLS1 expression.
Zhang SP; Li X; Li H; Sun XH; Yan XF
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6538-6544. PubMed ID: 30338824
[TBL] [Abstract][Full Text] [Related]
29. Progression of aggressive metastatic carcinosarcoma after treatment of epithelioid osteosarcoma.
Amanatullah DF; Ngann KK; Borys D; Tamurian RM
Orthopedics; 2010 Jun; 33(6):445. PubMed ID: 20806764
[TBL] [Abstract][Full Text] [Related]
30. Painful mass adjacent to the tibial tubercle of a 14-year-old boy. Periosteal osteosarcoma.
Johnston JO; Steinbach LS; Gelb AB
Clin Orthop Relat Res; 1997 Jun; (339):282-4, 288. PubMed ID: 9186230
[No Abstract] [Full Text] [Related]
31. Recurrence of osteosarcoma after intraoperative radiation therapy.
Nakayama T; Tsuboyama T; Toguchida J; Tanaka C; Oya N; Hiraoka M; Nakamura T
Orthopedics; 2005 Oct; 28(10):1195-7. PubMed ID: 16237885
[No Abstract] [Full Text] [Related]
32. MR imaging based strategies in limb salvage surgery for osteosarcoma of the distal femur.
van Trommel MF; Kroon HM; Bloem JL; Hogendoorn PC; Taminiau AH
Skeletal Radiol; 1997 Nov; 26(11):636-41. PubMed ID: 9428070
[TBL] [Abstract][Full Text] [Related]
33. Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: an Italian sarcoma group trial ISG/OS-1.
Ferrari S; Ruggieri P; Cefalo G; Tamburini A; Capanna R; Fagioli F; Comandone A; Bertulli R; Bisogno G; Palmerini E; Alberghini M; Parafioriti A; Linari A; Picci P; Bacci G
J Clin Oncol; 2012 Jun; 30(17):2112-8. PubMed ID: 22564997
[TBL] [Abstract][Full Text] [Related]
34. [Goal and results of the COSS study].
Flege S; Bielack S
Handchir Mikrochir Plast Chir; 2004 Oct; 36(5):282-8. PubMed ID: 15503258
[TBL] [Abstract][Full Text] [Related]
35. Treatment of large osteosarcoma in children: new approach.
Kobys VL; Konovalenko VF; Repinа NV; Golovko TS; Gulak LO; Tarasova TO; Zaharycheva EV; Matyushok OF
Exp Oncol; 2013 Jun; 35(2):105-8. PubMed ID: 23828385
[TBL] [Abstract][Full Text] [Related]
36. Primary bone osteosarcoma in the pediatric age: state of the art.
Longhi A; Errani C; De Paolis M; Mercuri M; Bacci G
Cancer Treat Rev; 2006 Oct; 32(6):423-36. PubMed ID: 16860938
[TBL] [Abstract][Full Text] [Related]
37. Outcomes in non-metastatic treatment naive extremity osteosarcoma patients treated with a novel non-high dosemethotrexate-based, dose-dense combination chemotherapy regimen 'OGS-12'.
Bajpai J; Chandrasekharan A; Talreja V; Simha V; Chandrakanth MV; Rekhi B; Khurana S; Khan A; Vora T; Ghosh J; Banavali SD; Gupta S
Eur J Cancer; 2017 Nov; 85():49-58. PubMed ID: 28888849
[TBL] [Abstract][Full Text] [Related]
38. The efficacy and safety comparison of first-line chemotherapeutic agents (high-dose methotrexate, doxorubicin, cisplatin, and ifosfamide) for osteosarcoma: a network meta-analysis.
Zhang B; Zhang Y; Li R; Li J; Lu X; Zhang Y
J Orthop Surg Res; 2020 Feb; 15(1):51. PubMed ID: 32054494
[TBL] [Abstract][Full Text] [Related]
39. Pirarubicin versus doxorubicin in neoadjuvant/adjuvant chemotherapy for stage IIB limb high-grade osteosarcoma: does the analog matter?
Yu W; Tang L; Lin F; Yao Y; Shen Z
Med Oncol; 2015 Jan; 32(1):307. PubMed ID: 25432694
[TBL] [Abstract][Full Text] [Related]
40. Progression of osteosarcoma after high-dose methotrexate: over-rescue by folinic acid.
Cohen IJ
Pediatr Hematol Oncol; 2003 Dec; 20(8):579-81. PubMed ID: 14578026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
